Determining the factors that impact single stranded DNA mutagenesis
确定影响单链 DNA 突变的因素
基本信息
- 批准号:10713599
- 负责人:
- 金额:$ 37.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcetaldehydeAlkylating AgentsBypassCell Culture TechniquesCell CycleCellsComplexDNA BindingDNA DamageDNA RepairDNA damage checkpointDNA glycosylaseDataGeneticGenomic InstabilityGoalsHumanIndividualKnowledgeLaboratoriesMalignant NeoplasmsMutagenesisMutagensMutationOutcomePathway interactionsPatternPolymerasePositioning AttributePredispositionPreventive measureProteinsReporterResearchResearch Project GrantsRoleSS DNA BPScientific Advances and AccomplishmentsSingle-Stranded DNASpecificityStretchingSystemWorkYeastsbioinformatics toolinterdisciplinary approachlarge datasetsnext generation sequencingpreventprogramsreplication factor Atool
项目摘要
Abstract
Single stranded DNA (ssDNA) has been demonstrated to by extremely vulnerable to DNA damage. Cancers
often carry long stretches of clustered mutations that likely arose due to damage of ssDNA. While, various
studies have demonstrated that certain mutagens preferentially damage ssDNA, the mechanisms that alter
mutation specificity due to damage in ssDNA and the pathways that prevent mutagenesis at ssDNA are
unknown. The overarching goal of this proposal is to specifically identify the roles of DNA damage checkpoint
proteins, translesion polymerases, ssDNA-specific glycosylases and ssDNA binding proteins in altering the
mutation patterns obtained upon ssDNA-specific damage. My laboratory is in a unique position to advance this
scientific front based on my strong track record in DNA damage and repair, assembled team of collaborators,
and multidisciplinary approach. My expertise in using highly sensitive yeast reporter systems, human cell
culture techniques and the use of bioinformatics tools to probe large data sets and to analyze next generation
sequencing data allow us to develop our research program to understand the pathways modulating ssDNA
mutagenesis in yeast and human cells. Previously, I have demonstrated that alkylating agents and
acetaldehyde have an ssDNA-specific mutation signature in yeast and in cancers. These mutation signatures
provide us with a highly sensitive tool to determine how changes in various DNA repair, damage bypass and
damage sensing pathways alter mutagenesis by ssDNA-specific mutagens. Here, we propose to determine 1)
How cell cycle dependent translesion polymerase expression alters mutation signatures in ssDNA; 2) The role
of ssDNA binding Replication Protein A complex in protecting ssDNA from exogenous damage; 3) The role of
DNA damage checkpoint activation in modulating the mutation signatures associated with ssDNA damage; 4)
Which DNA glycosylases function on ssDNA and alter the mutation signatures due to ssDNA damage; and 5)
What are the mutagenic outcomes when translesion polymerases are unable to bypass ssDNA damage. This
set of research projects will address a key gap in knowledge in understanding the mechanisms that alter the
hypermutability of ssDNA in cells. Our work will enable us to identify and develop better cancer preventative
measures for individuals who are prone to increased genome instability and ssDNA formation in their cells.
摘要
单链DNA(ssDNA)已被证明非常容易受到DNA损伤。癌症
通常携带很长一段簇状突变,可能是由于ssDNA的损伤而引起的。虽然,各种
研究表明,某些诱变剂优先损伤ssDNA,改变ssDNA的机制是,
由于ssDNA中的损伤引起的突变特异性和防止ssDNA处的诱变的途径是
未知该提案的总体目标是明确确定DNA损伤检查点的作用
蛋白质、跨损伤聚合酶、ssDNA特异性糖基化酶和ssDNA结合蛋白在改变肿瘤细胞中的表达中的作用。
在ssDNA特异性损伤后获得的突变模式。我的实验室处于一个独特的位置来推进这一点
科学前沿基于我在DNA损伤和修复方面的良好记录,组建了合作者团队,
多学科的方法。我在使用高灵敏度酵母报告系统,人类细胞
培养技术和使用生物信息学工具来探测大型数据集并分析下一代
测序数据使我们能够发展我们的研究计划,以了解调节ssDNA的途径
酵母和人类细胞中的诱变。以前,我已经证明,烷基化剂和
乙醛在酵母和癌症中具有ssDNA特异性突变特征。这些变异特征
为我们提供了一个高度敏感的工具,以确定如何在各种DNA修复,损害旁路和
损伤感应途径改变ssDNA特异性诱变剂的诱变。在这里,我们建议确定1)
细胞周期依赖性跨损伤聚合酶表达如何改变ssDNA中的突变特征; 2)
ssDNA结合复制蛋白A复合物在保护ssDNA免受外源性损伤中的作用;
在调节与ssDNA损伤相关的突变特征中的DNA损伤检查点激活; 4)
哪些DNA糖基化酶在ssDNA上起作用并由于ssDNA损伤而改变突变特征;以及5)
当跨损伤聚合酶不能绕过ssDNA损伤时,会产生什么样的致突变结果?这
一系列研究项目将解决在理解改变人类行为的机制方面的一个关键知识缺口。
ssDNA在细胞中的超突变性。我们的工作将使我们能够识别和开发更好的癌症预防
这些措施适用于那些容易在细胞中增加基因组不稳定性和ssDNA形成的个体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Natalie Saini其他文献
Natalie Saini的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Natalie Saini', 18)}}的其他基金
Burden and signatures of somatic mutations in genomes of healthy individuals.
健康个体基因组体细胞突变的负担和特征。
- 批准号:
10305700 - 财政年份:2020
- 资助金额:
$ 37.75万 - 项目类别:
Burden and signatures of somatic mutations in genomes of healthy individuals.
健康个体基因组体细胞突变的负担和特征。
- 批准号:
10290546 - 财政年份:2020
- 资助金额:
$ 37.75万 - 项目类别:
Burden and signatures of somatic mutations in genomes of healthy individuals.
健康个体基因组体细胞突变的负担和特征。
- 批准号:
10515317 - 财政年份:2020
- 资助金额:
$ 37.75万 - 项目类别:
相似海外基金
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
- 批准号:
10374792 - 财政年份:2021
- 资助金额:
$ 37.75万 - 项目类别:
Elucidation and prevention of the mechanism of hepatic sinusoidal obstruction syndrome (SOS) induced by DNA alkylating agents
DNA烷化剂诱发肝窦阻塞综合征(SOS)机制的阐明和预防
- 批准号:
21K15255 - 财政年份:2021
- 资助金额:
$ 37.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
- 批准号:
10570900 - 财政年份:2021
- 资助金额:
$ 37.75万 - 项目类别:
Development of individualized therapy by elucidation of molecular mechanisms for hypermutation phenotype induced by treatment with alkylating agents in glioma
通过阐明神经胶质瘤中烷化剂治疗诱导的超突变表型的分子机制来开发个体化治疗
- 批准号:
18K09004 - 财政年份:2018
- 资助金额:
$ 37.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Reversing intrinsic cancer cell resistance to alkylating agents by histone deacetylase inhibition
通过组蛋白脱乙酰酶抑制逆转癌细胞对烷化剂的内在耐药性
- 批准号:
214657440 - 财政年份:2012
- 资助金额:
$ 37.75万 - 项目类别:
Research Grants
Rerouting alkylating agents to the mitochondria for cancer therapy
将烷化剂重新路由至线粒体用于癌症治疗
- 批准号:
247842 - 财政年份:2011
- 资助金额:
$ 37.75万 - 项目类别:
Studentship Programs
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8105413 - 财政年份:2010
- 资助金额:
$ 37.75万 - 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8271313 - 财政年份:2010
- 资助金额:
$ 37.75万 - 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8730259 - 财政年份:2010
- 资助金额:
$ 37.75万 - 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
- 批准号:
8676463 - 财政年份:2010
- 资助金额:
$ 37.75万 - 项目类别: